Market by Product, Technology, Application, Industry Vertical, and Country Outlook | Forecast 2021-2028
Triton Market Research
envisions the Asia-Pacific DNA sequencing market to witness growth, with a CAGR
of 17.80% over the forecasting period from 2021 to 2028.
Report scope can be customized per your requirements. Request For Customization
The countries
considered in this market include:
• China
• Japan
• India
• South Korea
• Australia & New Zealand
• ASEAN countries
• Rest of APAC countries
The increasing
expenditure on research & development, the availability of advanced
technology for drug discovery & development, and its growing adoption are
positively influencing the growth of the DNA sequencing market in China. The
rising R&D activities by pharma and biopharma companies are another major
factor escalating the market growth. Further, with the rise in research in
genomics globally, the nation is also following suit. For instance, in December
2019, Genetron Health announced that it received approval for Genetron S5, the
firm’s clinical next-generation sequencing system, from the National Medical
Products Association. In June 2020, the gene-sequencing company, MGI Tech,
received a funding worth USD 1 billion from Citic Private Equity Funds
Management and IDG Capital. A few months later, in December, Illumina Inc’s
NextSeq 550Dx, received a go-ahead from the National Medical Products
Administration (NMPA) of China, for genetic testing and diagnosis purposes.
On the other hand, the
Japanese DNA sequencing market is also expected to thrive, thanks to factors
such as the rising R&D activities and technological progress in DNA
sequencing. The growing expenditure on R&D, especially in healthcare and
DNA sequencing, is expected to boost the demand for DNA sequencing in Japan.
For instance, in February 2020, ACTmed (Japan), Tokyo Medical and Dental
University (TMDU), and ACT Genomics (Taipei, Taiwan), joined hands to conduct
research, with a goal of establishing comprehensive genomic profiles of highly
prevalent cancers in the country’s population.
Established in 1999,
with the vision of using genomics for the benefit of humanity, BGI Genomics has
become the world’s biggest genomic organization. The company lays a special
focus on research and applications in the areas of healthcare, conservation,
environment, and agriculture. It has a proven track record of high-profile,
innovative research, being featured in more than 1,000 publications. BGI
Genomics also contributes to the scientific community by publishing the
international research journal GigaScience. The China-based company is
headquartered in Yantian District, Shenzhen.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
DNA SEQUENCING MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE DNA SEQUENCING MARKET
2.2. KEY
INSIGHTS
2.2.1. APPLICATIONS
OF LIQUID BIOPSY
2.2.2. EMERGING
DEVELOPING ECONOMIES
2.2.3. DEVELOPMENT
IN PERSONALIZED MEDICINE AND BIOMARKER DISCOVERY
2.2.4. NEXT
GENERATION SEQUENCING
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. INDUSTRY
COMPONENTS
2.5. KEY
IMPACT ANALYSIS
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. KEY
MARKET STRATEGIES
2.8.1. CONTRACTS
AND PARTNERSHIPS
2.8.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.8.3. ACQUISITIONS
& MERGERS
2.8.4. NEW
PRODUCT LAUNCHES
2.9. MARKET
DRIVERS
2.9.1. PREVALENCE
OF CANCER CASES
2.9.2. ADVANCEMENTS
IN TECHNOLOGY
2.9.3. APPLICATIONS
OF DNA SEQUENCING FOR ANIMALS & PLANTS REPRODUCTION
2.10. MARKET
RESTRAINTS
2.10.1. CHALLENGES
ASSOCIATED WITH DNA SEQUENCING TECHNOLOGIES IN BIOINFORMATICS
2.10.2. LACK
OF SKILLED PROFESSIONALS IN EMERGING ECONOMIES
2.10.3. LIMITATIONS
OF DNA SEQUENCING TECHNOLOGY IN DIAGNOSTIC TESTING
2.11. MARKET
OPPORTUNITIES
2.11.1. EXTENSIVE
RESEARCH AND DEVELOPMENT IN DNA SEQUENCING
2.11.2. GROWTH
IN GENOME MAPPING PROGRAMS
3. ASIA-PACIFIC
DNA SEQUENCING MARKET – BY PRODUCT
3.1. INSTRUMENTS
& CONSUMABLES
3.1.1. INSTRUMENTS
& CONSUMABLES TYPE
3.1.1.1. CONSUMABLES
3.1.1.2. INSTRUMENTS
3.1.2. INSTRUMENTS
& CONSUMABLES PLATFORM
3.1.2.1. NGS
(NEXT GENERATION SEQUENCING)
3.1.2.1.1. RNA
SEQUENCING
3.1.2.1.2. TARGETED
RESEQUENCING
3.1.2.1.3. WHOLE-EXOME
SEQUENCING
3.1.2.1.4. WHOLE-GENOME
SEQUENCING
3.1.2.1.5. CHIP
SEQUENCING
3.1.2.1.6. DE
NOVO SEQUENCING
3.1.2.1.7. METHYL
SEQUENCING
3.1.2.2. SANGER
3.2. SEQUENCING
SERVICES
3.3. BIOINFORMATICS
4. ASIA-PACIFIC
DNA SEQUENCING MARKET – BY TECHNOLOGY
4.1. SEQUENCING
BY SYNTHESIS
4.2. ION
SEMICONDUCTOR SEQUENCING
4.3. CHAIN
TERMINATION SEQUENCING
4.4. PYROSEQUENCING
4.5. SEQUENCING
BY LIGATION (SBL)
4.6. SINGLE-MOLECULE
REAL-TIME SEQUENCING (SMRT)
4.7. NANOPORE
SEQUENCING
4.8. OTHER
TECHNOLOGIES
5. ASIA-PACIFIC
DNA SEQUENCING MARKET – BY APPLICATION
5.1. BIOMARKER
DISCOVERY
5.2. DIAGNOSTICS
5.3. REPRODUCTIVE
HEALTH
5.4. PERSONALIZED
MEDICINE
5.5. DRUG
DISCOVERY
5.6. AGRICULTURE
& ANIMAL RESEARCH
5.7. FORENSICS
5.8. OTHER
APPLICATIONS
6. ASIA-PACIFIC
DNA SEQUENCING MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH
CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
6.2. PHARMACEUTICAL
6.3. BIOTECHNOLOGY
COMPANIES
6.4. HOSPITALS
& CLINICS
6.5. OTHER
INDUSTRY VERTICALS
7. ASIA-PACIFIC
DNA SEQUENCING MARKET – COUNTRY OUTLOOK
7.1. CHINA
7.2. JAPAN
7.3. INDIA
7.4. AUSTRALIA
& NEW ZEALAND
7.5. SOUTH
KOREA
7.6. ASEAN
COUNTRIES
7.7. REST
OF ASIA-PACIFIC
8. COMPETITIVE
LANDSCAPE
8.1. ADAPTIVE
BIOTECHNOLOGIES INC
8.2. AGILENT
TECHNOLOGIES INC
8.3. ASURAGEN
INC
8.4. BGI
GENOMICS
8.5. BIO-RAD
LABORATORIES INC
8.6. DANAHER
CORPORATION (INTEGRATED DNA TECHNOLOGIES INC)
8.7. EUROFINS
SCIENTIFIC
8.8. F
HOFFMANN-LA ROCHE
8.9. ILLUMINA
INC
8.10. MERCK
KGAA
8.11. PACIFIC
BIOSCIENCES OF CALIFORNIA INC
8.12. PERKINELMER
INC
8.13. SIEMENS
HEALTHINEERS AG
8.14. SPIRAL
GENETICS INC
8.15. THERMO
FISHER SCIENTIFIC INC
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: ASIA-PACIFIC DNA SEQUENCING MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: CONTRACTS AND PARTNERSHIPS
TABLE 4: BUSINESS EXPANSIONS, ANNOUNCEMENTS &
DIVESTITURES
TABLE 5: ACQUISITIONS & MERGERS
TABLE 6: NEW PRODUCT LAUNCHES
TABLE 7: ASIA-PACIFIC DNA SEQUENCING MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC INSTRUMENTS &
CONSUMABLES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC INSTRUMENTS &
CONSUMABLES MARKET, BY PLATFORM, 2021-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC NGS MARKET, BY TYPE, 2021-2028
(IN $ MILLION)
TABLE 11: ASIA-PACIFIC DNA SEQUENCING MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC DNA SEQUENCING MARKET, BY
APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC DNA SEQUENCING MARKET, BY
INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 14: ASIA-PACIFIC DNA SEQUENCING MARKET, COUNTRY
OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: ASIA-PACIFIC DNA
SEQUENCING MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: LIMITATIONS OF DNA
SEQUENCING IN DIAGNOSTIC TESTING
FIGURE 3: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 4: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY INSTRUMENTS & CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 5: ASIA-PACIFIC
INSTRUMENTS & CONSUMABLES MARKET, BY CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC
INSTRUMENTS & CONSUMABLES MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 7: ASIA-PACIFIC
INSTRUMENTS & CONSUMABLES MARKET, BY NGS, 2021-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC NGS
MARKET, BY RNA SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC NGS
MARKET, BY TARGETED RESEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC NGS MARKET,
BY WHOLE-EXOME SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC NGS MARKET,
BY WHOLE-GENOME SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC NGS MARKET,
BY CHIP SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC NGS MARKET,
BY DE NOVO SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC NGS MARKET,
BY METHYL SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC INSTRUMENTS
& CONSUMABLES MARKET, BY SANGER, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY SEQUENCING SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY BIOINFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 19: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY SEQUENCING BY SYNTHESIS, 2021-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY ION SEMICONDUCTOR SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY CHAIN TERMINATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY PYROSEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY SEQUENCING BY LIGATION (SBL), 2021-2028 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT), 2021-2028
(IN $ MILLION)
FIGURE 25: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY NANOPORE SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 28: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY BIOMARKER DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 30: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC DNA SEQUENCING
MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
FIGURE 32: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
FIGURE 33: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY AGRICULTURE & ANIMAL RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 34: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 35: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 36: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 37: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT
INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 38: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY PHARMACEUTICAL, 2021-2028 (IN $ MILLION)
FIGURE 39: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 40: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 41: ASIA-PACIFIC DNA
SEQUENCING MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 42: CHINA DNA SEQUENCING
MARKET 2021-2028 (IN $ MILLION)
FIGURE 43: JAPAN DNA SEQUENCING
MARKET 2021-2028 (IN $ MILLION)
FIGURE 44: INDIA DNA SEQUENCING
MARKET 2021-2028 (IN $ MILLION)
FIGURE 45: AUSTRALIA & NEW
ZEALAND DNA SEQUENCING MARKET 2021-2028 (IN $ MILLION)
FIGURE 46: SOUTH KOREA DNA
SEQUENCING MARKET 2021-2028 (IN $ MILLION)
FIGURE 47: ASEAN COUNTRIES DNA
SEQUENCING MARKET 2021-2028 (IN $ MILLION)
FIGURE 48: REST OF ASIA-PACIFIC DNA
SEQUENCING MARKET 2021-2028 (IN $ MILLION)